Thank you for placing us in the Top 75 Trading Blogs And Websites For Traders


Thank you which is a polite expression used when acknowledging a gift, service, or a compliment.

Team StockArchitect would like to thank each one of their users, readers and followers. Thanks solely to your support, we have been ranked as #42 in the Top 75 Trading Blogs And Websites For Traders by feedspot.com.

We are truly humbled by this recognition and it is thanks to each one of YOU – Our users, followers and readers.

We promise to work harder and bring to you more tools, more posts and relevant content.

Committed to your service,

Team StockArchitect


Reblog: 20 Reasons Why 90% of New Traders Don’t Make It


  1. They risk too much to try to make so little.
  2. They trade with the probabilities against them.
  3. They think trading is easy money.
  4. Instead of focusing on learning how to trade they focus on getting rich.
  5. They blow up due to improper position sizing.
  6. With no understanding of the mathematical risk of ruin they are doomed after the first long string of losing trades.
  7. Blindly following a guru that leads them down the road of destruction.
  8. They don’t do their homework.
  9. They trade opinions not robust systems.
  10. They go looking for ‘trades’ instead of a methodology.
  11. They have no trading plan.
  12. They attempt to piggy back on the trades another trader but don’t understand the risks.
  13. Most new traders quit when they realized how much work is involved in trading successfully.
  14. Most traders quit when they learn how many losing trades they will have to have to get to the winners.
  15. New traders quit if they do not have a passion for trading itself.
  16. Many new traders will give up the moment they realize that trading does not have guaranteed income, you are an entrepreneur.
  17. They are not willing to pay the tuition to learn to trade in time, study, and losing trades.
  18. They are crushed by the learning curve that they do not work hard enough to get through.
  19. We lose a lot of new traders when they realize that trading is actually harder than their job.
  20. The traders that don’t make it quit when they were tired, frustrated, and stressed out, the winning traders quit after they had figured trading out.

The original article appears on newtraderu.com and is penned by Steve Burns. It can be accessed here.


Reblog: Godrej Agrovet IPO review


Godrej Agrovet Ltd. (GAL) is a well diversified, research and development focused agri-business company with operations across five business verticals i.e. animal feed, crop protection, oil palm, dairy, and poultry and processed foods. GAL is the leading compound animal feed company in India, on the basis of installed capacity for the financial year 2016. In Bangladesh, its joint venture, ACI Godrej was the fourth largest feed producer, in terms of sales volume, during the financial year 2016. It is also the largest crude palm oil producer in India, in terms of market share, as of March 31, 2017.

In animal feed business, GAL’s portfolio of products comprises cattle feed, poultry feed (broiler and layer), aqua feed (fish and shrimp) and specialty feed. Animal feed products are manufactured at 35 facilities, of which 10 facilities are owned and seven are operated by it, located near major consumption centers across India, with an aggregate production capacity of 2.36 million MT per annum, as of June 30, 2017. Company’s pan-India distribution network for animal feed products includes approximately 4,000 distributors, as of June 30, 2017.

In crop protection business, GAL manufactures a wide range of products that cater to the entire crop lifecycle including plant growth regulators, organic manures, generic agrochemicals and specialized herbicides. In October 2015 it acquired a majority equity interest in Astec LifeSciences (ALS) and currently own 56.82% of the outstanding equity shares. ALS manufactures agrochemical active ingredients (technical), bulk and formulations as well as intermediate products and sells its products in India as well as exports them to approximately 24 countries, including the United States and countries across Europe, West Asia, South East Asia and Latin America. ALS also undertakes contract development and manufacturing services for other agrochemical companies. ALS sells all its products to institutional customers, while GAL sells its products primarily to retail consumers. The distribution network of Company’s crop protection business in India includes approximately 6,000 distributors, as of June 30, 2017.

In oil palm business, GAL produces a range of products including crude palm oil, crude palm kernel oil and palm kernel cake. The company purchases fresh fruit bunches (“FFBs”) from palm oil farmers and work closely with them by providing planting material, agricultural inputs and technical guidance. It has entered into memoranda of understanding with nine state governments, which provides the company with access to approximately 61,700 hectares under oil palm plantation, which is equivalent to approximately one-fifth of India’s area suitable for oil palm cultivation, as of March 31, 2017. This public-private partnership model, which, has been promoted by the Government of India, allows GAL to maintain an asset-light business model. The company works closely with farmers in it’s designated area to plant oil palm on their farmland and provide technical guidance and assistance. The company has set up five palm oil mills in India with an aggregate FFB processing capacity of 125 MT per hour and a palm kernel processing capacity of seven MT per hour, as of June 30, 2017. GAL is recognized as the ‘Highest Crude Palm Oil Producer in the Country’.

In dairy business, which it operates through Subsidiary, Creamline Dairy, it sells a majority of milk and milk-based products under the ‘Jersey’ brand across the states of Telangana, Andhra Pradesh, Tamil Nadu, Karnataka and Maharashtra. As of June 30, 2017, it owned and operated nine milk processing units. For dairy business, supply chain network includes procurement from six states through a network of 120 chilling centers, as of June 30, 2017. As on the same date, it’s dairy distribution network included approximately 4,000 milk distributors, approximately 3,000 milk product distributors and 50 retail parlours, as well as direct sales to institutional customers.

GAL also manufactures and market processed poultry and vegetarian products through its brands ‘Real Good Chicken’ and ‘Yummiez’. To grow its poultry and processed foods business, company has entered into a joint venture with Tyson India Holding Limited, a subsidiary of Tyson Foods Inc., U.S.A. This helps GAL with the technical and operational expertise to compete successfully in India. The company has set up two processing plants with integrated breeding and hatchery operations and has a diverse customer base comprising of retail customers as well as institutional clients such as quick service restaurants, fine dining restaurants, food service companies and hotels.

To part finance its repayment/pre-payment of working capital facilities, repayment of commercial paper and general corpus fund needs, GAL is coming out with a maiden IPO for fresh equity issue worth Rs. 300 crore and offer for sale of Rs. 300 crore by Godrej Industries and 12300000 equity shares under OFS by V-Science Investment Pte. Issue is being made via book building route with a price band of Rs. 450 to Rs. 460 for a share having face value of Rs. 10 each. Company has reserved shares worth Rs. 20 crore for eligible employees. Issue opens for subscription on 04.10.17 and will close on 06.10.17. Total issue size is Rs. 1157 crore including pre-IPO placements. Minimum application is to be made for 32 shares and in multiples thereon, thereafter. Post allotment, shares will be listed on BSE and NSE. BRLMs to this offer are Kotak Mahindra Capital Co. Ltd., Axis Capital Ltd. and Credit Suisse Securities (India) Pvt. Ltd. Kavry Computershare Pvt. Ltd. is the registrar to the issue. Having issued initial equity at par in 1991-92, company raised further equity in the price range of Rs. 82 to Rs. 2164.41 per share. It has also issued bonus shares in the ratio of 3 for 1 in March 1994, 6 for 1 in March 2015 and 1 for 1 in March 2017. In September 2017 it issued 192901 shares at a price of Rs. 440 per share under pre-IPO placement, thus the fresh issue size stands reduced to Rs. 291.51 crore (approx 6337390 shares) that includes reserve quota for employees. Post issue, GAL’s current paid up equity capital of Rs. 185.32 crore will stand enhanced to around Rs. 191.66 crore.

On performance front, GAL has (on a consolidated basis) posted turnover/net profits of Rs.3117.42 cr. / Rs. 156.56 cr. (FY14), Rs. 3325.50 cr. / Rs. 210.13 cr. (FY15), Rs. 3817.67 cr. / Rs. 261.09 cr. (FY16) and Rs. 4983.45 cr. / Rs. 274.39 cr. (FY17). For Q1 of the current fiscal, it has reported net profit of Rs. 74.29 crore on a turnover of Rs. 1369.42 cr. It has posted an average EPS of Rs. 10.02 and average RoNW of 23.86% for last three fiscals on a paid up equity capital of Rs.185.13 cr. Issue is priced at a P/BV of 7.88. If we annualize latest earnings and attribute it on fully diluted equity post issue, then asking price is at a P/E of around 30. It has no listed peers to compare with. Issue is priced justifiably considering the diverse activities.

On BRLM’s front, three merchant bankers associated with this issue have handled 42 public issues in past three fiscal years out of which 11 issues closed below the issue price on listing date.

Conclusion: After long, a well diversified company from the house of Godrej is coming with a maiden offer. Company is playing major role in all its verticals and is poised for better prospects. Investment may be considered for short to long term.

The original review is authored by Dilip Davda, appears on Chittorgarh.com and is available here.


Reblog: SBI Life Insurance IPO review


SBI Life Insurance Co. Ltd. (SBI Life) is a life insurance arm of SBI group that is coming out with a public offer after 23 years gap. The last issue was in 1994 for SBI.

SBI Life India’s largest private life insurer, in terms of New Business Premium generated in each fiscal year, since Fiscal 2010. It has also increased its market share of New Business Premium generated among private life insurers in India, from 15.87% in Fiscal 2015 to 20.04% in Fiscal 2017. Between Fiscal 2015 and Fiscal 2017, SBI Life’s New Business Premium generated increased at a CAGR of 35.45%, which is the highest among the top five private life insurers (in terms of total premium in Fiscal 2017) in India.

Continue Reading


Reblog: The Importance Of Time Horizons For Investing (And Beyond)


The Importance of Time Horizons

 When it comes to evaluating market risk, your time horizon is a key factor to consider. As a general rule, shorter time horizons require more caution than do longer ones. I would also argue, however, that this concept applies to many areas of investing—and beyond.

Long-term investing

Let’s start with why longer-term results can be more predictable than shorter-term ones. The answer is, simply, averaging. One data point might be noisy, but as you accumulate more and average them, the outliers tend to offset each other. As a result, the signal starts to dominate the noise. The more data points you have, the closer you get to the expected result. Investors with 40 years, for example, can look at longer-term return goals with a reasonable expectation of actually getting them. But for shorter time frames, the noise can dominate. Hence, the extra caution needed as you get closer to retirement.

Continue Reading


Reblog: Psychology of fear


 

The stock market has a long history of humbling investors. The Investment Masters understand the need for humility. Ordinarily, when investors have had a good run they risk getting over-confident and letting down their guard, only to have the stock market deliver them losses.

Many of the Investment Masters maintain a psychology of fear.

“It is better if you invest scared, if you worry about losing money, if you worry about being wrong, if you worry about being overconfident because these are the things you want to avoid. They should be foremost in your mind.” Howard Marks

“We are big fans of fear, and in investing it is clearly better to be scared than sorry.” Seth Klarman Continue Reading


Sensex snaps 2-day losing streak; Nifty ends week above 10,050; IOC, HPCL zoom


The benchmark indices erased entire losses to settle near day’s high thanks to gains in metal, oil & gas and banking stocks, while the pharma index was the sole sectoral loser. Almost all constituents of the Nifty pharma index, which shed as much as 2.5% intraday, were in red.

The Sensex ended at 32,325, up 87 points, while the Nifty50 closed at 10,066, up 52 points. Both indices settled the week marginally higher.

Metals and oil marketing companies also led support to the market but the correction in Reliance Industries and healthcare stocks capped gains. Equity benchmarks opened lower and remained range bound till recovery in later part of the session.

In the broader market, the BSE Midcap outperformed to gain 0.6%, while the BSE Smallcap index settled little changed.

The breadth, indicating the overall health of the market, was negative. On the BSE, 1,388 shares fell and 1,198 shares rose. A total of 172 shares remained unchanged.

Continue Reading


Nifty ends marginally lower but holds above 10,000 , up 1% for week


The benchmark Nifty50 pared losses in the last leg of trade to end the first day of August series above 10,000-mark, up 1% for the week. Sensex, on the other hand, also ended marginally lower for the day but up 1% for the week. The street was dragged down by after Dr. Reddy’s extended fall for the second straight day post weaker Q1 quarterly earnings. Negative cues from Asian markets after US tech shares pulled Wall Street slightly lower also contributed to the losses.

Broader markets outperformed benchmark indices with BSE Midcap and BSE Smallcap, up 0.5% and 0.4% respectively.

Focus now shifts to Reserve Bank of India’s two-day monetary policy meeting, which is set to begin next week on Tuesday, while the outcome is expected on Wednesday.

HDFC, Infosys, Kotak Mahindra Bank, Adani Ports and ONGC gained the most on BSE Sensex while Dr Reddy’s, Sun Pharma, Lupin, ICICI Bank and HeroMoto Corp lost the most on the index

Continue Reading


Reblog: Investing is not Rocket Science! Here’s Why…


Owing to its irrational nature, people often assume that investing in the stock market is a rather difficult affair. Many even compare it to gambling and consider it impossible. With the amount of negative opinions regarding the stock market, it seems like a place where everybody loses. We have to set the record straight, once and for all.

Investing is not rocket science and investing in the stock market is relatively easy to manage if you do it the right way. Your mindset is the one stopping you from investing and it will be the one that will help you invest. Everyone has their own opinions about the market and a lot of people make it difficult for themselves, more than necessary.

Continue Reading


Reblog: Quality Companies, Compounders and Value Traps – Investment Masters Class


sees-candy

Many of the great investors evolve over time to focus on high quality companies.  In the post ‘Evolution of a Value Manager’ I outlined how Buffett, with insight from Munger and the acquisition of See’s Candy transitioned from seeking cheap companies [ie cheap PE/, price/book etc] to trying to purchase high quality companies at reasonable prices.  Li Lu and Mohnish Pabrai are two Buffett disciples who have made a similar transition.

Continue Reading